1. Launch of the FEAM statement on Mental Health Policy Issues Launch of the FEAM statement on Mental Health Policy Issues 22 March 2011 European Parliament, Brussels Welcome!

2. Few words about FEAM FEAM was founded in 1993 in Brussels Objective: –promoting cooperation with the national Academies of Medicine –extending the advisory role that the Academies exercise in their own countries on matters concerning medicine and public health to the political and administrative authorities of the European Union. Nat. Acad. of 13 European member states: Austria, Belgium, Czech Republic, France, Germany, Greece, Hungary, Italy, Portugal, Netherlands, Romania, Spain and United Kingdom. To better reflect the European diversity, it seeks to involve additional Academies in its scientific activities and by collaborating with other European networks on matters of common interest.

3. Like its member Academies, FEAM is independent from political, ideological and commercial interests and provides evidence-based scientific advice. It is governed by four elected FEAM Officers: President: Prof. Hubert E. Blum (German National Academy of Sciences Leopoldina) Vice President: Prof. Laurentiu Popescu (Romanian Academy of Medical Sciences) Treasurer: Prof. F. Rubia Vila ( Real Academia Nacional de Medicina) General Secretary: Prof. János Frühling (Académie Royale de Médecine de Belgique) and four advisory Officers: Prof. Cyril Höschl (Czech Medical Academy), Prof. Luigi Frati (Accademia Nazionale di Medicina), Sir Peter Lachmann (UK Academy of Medical Sciences) and Prof. Charles Pilet (Academie Nationale de Médecine de France) Its member Academies nominate national delegates who meet once a year as General Assembly (FEAM Spring conference).

4. Current priority topics Mental health policy issues Reforming the EU Clinical Trials Directive Personalised medicine and genetic testing as an instrument for disease prevention: evaluation of policy issues for direct consumer access Harmonising medical training in Europe Better integration of human and animal medicine

5. European mental health policy issues: the view from FEAM Cyril Höschl Past-President of FEAM, President of Czech Medical Academy, Director, Prague Psychiatric Centre

6. European mental health policy issues: the view from FEAM Cyril Höschl Past-President of FEAM, President of Czech Medical Academy, Director, Prague Psychiatric Centre

7. All brain disorders: 386b euro Health care costs: 135 Direct non-medical: 72 Indirect costs: 178 Cost of Brain Disorders in Europe Andlin-Sobocki P, Jonsson B et al. Eur J Neurol 2005, 12 Suppl 1:1-27 Mental Disorders 295b euro Neurological 84b euro Neurosurgical 7b euro Cost of brain disorders in Europe

8. Lancet Neurology 2003, 2:647 Brain research vs other research 35% of the burden of all diseases due to brain diseases 8% of EU health research funding 17% of NIH health research funding

9. Brain research is underfunded Charity funding

10. 200820092002200320062007 Europe Against Cancer Ended Europe Against Cancer Ended Council Recommendation on Cancer Screening MEPs Against Cancer (MAC) group established European Parliament Written Declaration on Cancer Communication on Cancer Launch of Cancer Platform / partnership Communication on Cancer Launch of Cancer Platform / partnership Slovenian Presidency focus on Cancer (January -June) + Council Conclusions on Cancer (June) EP Resolution on Cancer (April) EC Report on Cancer Screening (June, December official) Slovenian Presidency focus on Cancer (January -June) + Council Conclusions on Cancer (June) EP Resolution on Cancer (April) EC Report on Cancer Screening (June, December official) EU CHANGES: New European Parliament and European Commission Moving a disease up the political agenda – the cancer example

11. FEAM activities on mental health policy September 2009 – scientific meeting in Prague to review new developments in psychiatry November 2010 – Statement to provide advice for developing coherent policy January 2011 – publication in European Psychiatry to stimulate further discussion March 2011 – European Parliament event to share views and clarify options for change Ongoing activity – academies at national level

12. Promotion of mental health is receiving increasing attention European Commission Green Paper 2005 European Parliament Resolution 2009 But there is much more to be done: …brain diseases, of which mental illnesses are the most costly to European society, are not a high enough priority for politicians, the media, or the general public. (Celso Arango, Parliament Magazine, 2010)

13. What are key societal challenges associated with mental ill-health? FEAM analysis of cross-cutting issues for policy: Stigma Suicide Employment Addiction Mental health in children and adolescents To be discussed further by other speakers

14. Priorities for research on mental disorders and their causes Basic and translational research: EU funding is relatively low New opportunities to integrate biological, epidemiological and social aspects Progress in clarifying gene-environment interaction but need standardised methodologies Strengthening research infrastructure: e.g., diagnostic imaging databases, brain banks Need for better EU coordination

15. Priorities for connecting research and innovation Understanding causes of under- and over- treatment and sharing good clinical practice across Member States Accelerating access to new treatments: No major breakthrough in schizophrenia in 50y and depression in 20y Declining pharmaceutical investments in CNS General problem of Clinical Trials Directive Value of academia-industry collaboration in new target identification and validation

16. Summary of FEAM recommendations Better understanding of psychosocial and biological factors and their interactions Capitalising on scientific advances and collaboration for more effective recognition and classification of mental disorders, further development of diagnostics and treatment methods Sharing best practice to attain consistently high standards of psychiatry throughout EU Success depends also on improved data collection, commitment to research and innovation priorities, and enhanced infrastructure

17. In conclusion: Generating and using new knowledge Requires coherent strategy and active networks across research, innovation and health services including partnerships from academia, industry, patient groups, funders and policy-makers Biomedical community has continuing responsibility to communicate about disorders, their determinants, prevention, and management FEAM academies can play vital role in analysing issues and encouraging scientific community to bring about change EBC have launched a call for 2014 to be the European Year of the Brain. The aims of the year are: Promoting an understanding of the economics of brain diseases and their management and ways to improve them Increasing the level of research funding of the brain research A longer term reduction in the burden of brain diseases Improvements in the quality of life for patients, their families and carers through initiatives led by, and delivered in, all Member States EBC have launched a call for 2014 to be the European Year of the Brain. The aims of the year are: Promoting an understanding of the economics of brain diseases and their management and ways to improve them Increasing the level of research funding of the brain research A longer term reduction in the burden of brain diseases Improvements in the quality of life for patients, their families and carers through initiatives led by, and delivered in, all Member States

18. FEAM Statement on Mental Health Policy Issues: http://www.feam.eu.com/publicationsEN.htm Thank you! FEAM, Palais des Académies, Rue Ducale 1, B-1000 Brussels